Skip to main
AHR

AHR Stock Forecast & Price Target

AHR Analyst Ratings

Based on 12 analyst ratings
Buy
Strong Buy 25%
Buy 67%
Hold 8%
Sell 0%
Strong Sell 0%

Bulls say

The positive outlook on American Healthcare REIT Inc. is underpinned by anticipated growth in acquisition activity, with potential additional investments projected at $600 million in 2026, enhancing their diversified portfolio. The company has experienced robust same-store cash Net Operating Income (NOI) growth, with forecasts suggesting a two-year compound annual growth rate (CAGR) of 11.8% for Trilogy and 15.5% for SHOP, reflecting improving operational efficiencies and a favorable market environment. Furthermore, the strengthened cost of capital positions American Healthcare REIT to pursue more aggressive and accretive capital deployment, potentially leading to superior external growth outcomes.

Bears say

American Healthcare REIT Inc faces several challenges that contribute to a negative outlook on its stock, primarily stemming from tenant risks and macroeconomic factors. A significant portion of the company's revenues is derived from its Integrated Senior Health Campuses segment, which includes skilled nursing facilities; thus, any deterioration in the financial health of tenants, particularly those reliant on Medicaid, could adversely impact earnings expectations. Additionally, the company is exposed to various operational risks, including regulatory changes affecting skilled nursing facilities, rising construction costs, and capital market volatility, all of which could hinder its ability to achieve organic net operating income growth and ultimately affect overall stock performance.

AHR has been analyzed by 12 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 67% recommend Buy, 8% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of American Healthcare REIT Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About American Healthcare REIT Inc (AHR) Forecast

Analysts have given AHR a Buy based on their latest research and market trends.

According to 12 analysts, AHR has a Buy consensus rating as of Mar 21, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $52.83, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $52.83, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

American Healthcare REIT Inc (AHR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.